Dabigatran reversal: Difference between revisions
m (moved Dabigatran (Pradaxa) to Dabigatran (Pradaxa) Reversal) |
|||
| Line 6: | Line 6: | ||
#Mild Bleeding | #Mild Bleeding | ||
##Local control measures | ##Local control measures | ||
##Delay next 1-2 | ##Delay next 1-2 doses OR discontinue (as appropriate) | ||
#Moderate-Severe Bleeding | #Moderate-Severe Bleeding | ||
##Local control measures/surgical intervention | ##Local control measures/surgical intervention | ||
## | ##IVF/blood | ||
##Oral [[charcoal]] administration (if taken <2hrs before) | ##Oral [[charcoal]] administration (if taken <2hrs before) | ||
##Hemodialysis (removes 60% over 2-3hrs) | ##Hemodialysis (removes 60% over 2-3hrs) | ||
Revision as of 20:25, 15 November 2012
Background
- If aPTT is normal (<1.5x control), it is unlikely that significant drug effect is present
- Thrombin Time (TT) is most sensitive; normal TT excludes presence of significant dabigatran
Reversal Protocol
- Mild Bleeding
- Local control measures
- Delay next 1-2 doses OR discontinue (as appropriate)
- Moderate-Severe Bleeding
- Local control measures/surgical intervention
- IVF/blood
- Oral charcoal administration (if taken <2hrs before)
- Hemodialysis (removes 60% over 2-3hrs)
- Life-Threatening Bleeding
- All above
- Consider:
- rFVIIa
- Prothrombin Complex Concentrate (PCC); (Trad Name = Cofact)
- 50 IU/kg IV bolus
Source
- Hennipin County Guidelines
- University of Utah Healthcare Thrombosis Service Guidelines
